United StatesThe article discusses the issue of expensive prescription medications in the United States, highlighting that cheaper alternatives exist but are not accessible to patients due to the influence of pharmaceutical middlemen. It suggests that both patients and their doctors are not in control of medication costs, implying systemic barriers within the healthcare system.
Bias read (Progressive): The article frames the high cost of medications as a result of corporate interests (middlemen) rather than market forces or individual choices. This perspective aligns with progressive critiques of the pharmaceutical industry and supports policies aimed at increasing transparency and reducing drug价格
